Published in PLoS One on July 03, 2014
Efficacy of the Theory of Planned Behaviour: a meta-analytic review. Br J Soc Psychol (2001) 13.22
Does changing behavioral intentions engender behavior change? A meta-analysis of the experimental evidence. Psychol Bull (2006) 7.28
Social networks and infectious disease: the Colorado Springs Study. Soc Sci Med (1994) 3.66
Concurrent partnerships and HIV prevalence disparities by race: linking science and public health practice. Am J Public Health (2009) 3.43
Sociometric risk networks and risk for HIV infection. Am J Public Health (1997) 3.29
Social network dynamics and HIV transmission. AIDS (1998) 3.14
Prophylactic vaccines, risk behavior change, and the probability of eradicating HIV in San Francisco. Science (1994) 2.98
Using social network and ethnographic tools to evaluate syphilis transmission. Sex Transm Dis (1998) 2.81
Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144. Lancet Infect Dis (2012) 2.68
Stochastic simulation of the impact of antiretroviral therapy and HIV vaccines on HIV transmission; Rakai, Uganda. AIDS (2003) 2.60
The importance of social networks in their association to drug equipment sharing among injection drug users: a review. Addiction (2007) 2.32
Network structural dynamics and infectious disease propagation. Int J STD AIDS (1999) 2.16
Outreach-based HIV prevention for injecting drug users: a review of published outcome data. Public Health Rep (1998) 2.08
Willingness to participate and enroll in a phase 3 preventive HIV-1 vaccine trial. J Acquir Immune Defic Syndr (2002) 2.02
Concurrent partnerships, acute infection and HIV epidemic dynamics among young adults in Zimbabwe. AIDS Behav (2012) 1.95
Risk behavior for HIV infection in participants in preventive HIV vaccine trials: a cautionary note. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 1.88
HIV sexual risk behavior over 36 months of follow-up in the world's first HIV vaccine efficacy trial. J Acquir Immune Defic Syndr (2005) 1.87
Sexual network analysis of a gonorrhoea outbreak. Sex Transm Infect (2004) 1.85
Disinhibition and risk compensation: scope, definitions, and perspective. Sex Transm Dis (2008) 1.41
Candidate HIV/AIDS vaccines: lessons learned from the World's first phase III efficacy trials. AIDS (2003) 1.40
Individual and network factors associated with prevalent hepatitis C infection among rural Appalachian injection drug users. Am J Public Health (2012) 1.35
The Likoma Network Study: Context, data collection, and initial results. Demogr Res (2009) 1.28
Forecasting the future of HIV epidemics: the impact of antiretroviral therapies & imperfect vaccines. AIDS Rev (2003) 1.28
Network structure and the risk for HIV transmission among rural drug users. AIDS Behav (2013) 1.23
Preventive HIV vaccine acceptability and behavioral risk compensation among high-risk men who have sex with men and transgenders in Thailand. Vaccine (2009) 1.21
Lack of increased HIV risk behavior among injection drug users participating in the AIDSVAX B/E HIV vaccine trial in Bangkok, Thailand. AIDS (2004) 1.18
Social network approaches to recruitment, HIV prevention, medical care, and medication adherence. J Acquir Immune Defic Syndr (2013) 1.12
Sexual risk behaviour of Canadian participants in the first efficacy trial of a preventive HIV-1 vaccine. CMAJ (2005) 1.11
Drug use and the risk of HIV infection amongst injection drug users participating in an HIV vaccine trial in Bangkok, 1999-2003. Int J Drug Policy (2010) 1.11
Social network-based interventions to promote condom use: a systematic review. AIDS Behav (2011) 1.10
Preventive HIV vaccine acceptability and behavioral risk compensation among a random sample of high-risk adults in Los Angeles (LA VOICES). Health Serv Res (2009) 1.07
HIV immunization: acceptability and anticipated effects on sexual behavior among adolescents. J Adolesc Health (1999) 1.04
Predicting the impact of a partially effective HIV vaccine and subsequent risk behavior change on the heterosexual HIV epidemic in low- and middle-income countries: A South African example. J Acquir Immune Defic Syndr (2007) 1.00
HIV risk and prevention in a post-vaccine context. Vaccine (2004) 0.98
A reexamination of connectivity trends via exponential random graph modeling in two IDU risk networks. Subst Use Misuse (2013) 0.97
HIV vaccine efficacy trial participation: men who have sex with men's experiences of risk reduction counselling and perceptions of risk behaviour change. AIDS Care (2005) 0.95
HIV vaccine trials: will intravenous drug users enroll? Am J Public Health (1994) 0.92
Will sexual risk behaviour increase after being vaccinated for AIDS? Int J STD AIDS (2006) 0.92
Modeling HIV vaccines in Brazil: assessing the impact of a future HIV vaccine on reducing new infections, mortality and number of people receiving ARV. PLoS One (2010) 0.91
The impact of a partially effective HIV vaccine on a population of intravenous drug users in Bangkok, Thailand: a dynamic model. J Acquir Immune Defic Syndr (2002) 0.91
Topological and Historical Considerations for Infectious Disease Transmission among Injecting Drug Users in Bushwick, Brooklyn (USA). World J AIDS (2013) 0.91
Behavioral and social issues among volunteers in a preventive HIV vaccine trial in Thailand. J Acquir Immune Defic Syndr (2005) 0.90
A social vaccine? Social and structural contexts of HIV vaccine acceptability among most-at-risk populations in Thailand. Glob Public Health (2012) 0.89
The potential impact of an HIV vaccine with rapidly waning protection on the epidemic in Southern Africa: examining the RV144 trial results. Vaccine (2011) 0.86
Perceptions of sexual risk compensation following posttrial HIV vaccine uptake among young South Africans. Qual Health Res (2012) 0.84
Sex, drugs, and race: how behaviors differentially contribute to the sexually transmitted infection risk network structure. Am J Public Health (2012) 0.83
Community preparedness for HIV vaccine trials in the Democratic Republic of Congo. Cult Health Sex (2006) 0.83
Perceived influence of an HIV vaccine on sexual-risk behaviour in the Dominican Republic. Cult Health Sex (2008) 0.80
Breaking the silence: what homeless 18- to 24-year-olds say about HIV vaccine trials. J Health Care Poor Underserved (2007) 0.79